Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
OPKO Health Inc banner

OPKO Health Inc
XBER:XCY

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
XBER:XCY
Watchlist
Price: 1.073 EUR
Market Cap: €2.9B
Write Note Create Alert Ask AI

Wall St Price Targets

XCY Price Targets Summary
OPKO Health Inc

Wall Street analysts forecast XCY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XCY is 4.523 EUR with a low forecast of 3.071 EUR and a high forecast of 9.047 EUR.

XCY Lowest Forecast
Wall Street Target
€3.071
186% Upside
XCY Average Forecast
Wall Street Target
€4.523
322% Upside
XCY Highest Forecast
Wall Street Target
€9.047
743% Upside
Lowest Forecast
Price Target
3.071 EUR
186% Upside
Average Forecast
Price Target
4.523 EUR
322% Upside
Highest Forecast
Price Target
9.047 EUR
743% Upside
OPKO Health Inc Competitors:
Price Targets
FAF
First American Financial Corp
0% Downside
FAF
First American Financial Corp
0% Downside

Revenue
Forecast

-15% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-15% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 8 years is 3%.

What are analyst estimates?

Gross Profit
Forecast

-6% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-6% / Year
Past Growth
6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Gross Profit has been -6%. The projected CAGR for the next 5 years is 6%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue XCY Research

Summary
XCY intrinsic value, competitors valuation, and company profile.
DCF Valuation
XCY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XCY stock valuation using valuation multiples.
Wall St Estimates
XCY price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XCY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other OPKO Health Inc listings:
NASDAQ • USD
OPK
 F • EUR
XCY
 TASE • ILS
OPK
 BMV • MXN
OPK
 XMUN • EUR
XCY
 SWB • EUR
XCY
 LSE • USD
0KCS
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is XCY's stock price target?
Price Target
4.523 EUR

According to Wall Street analysts, the average 1-year price target for XCY is 4.523 EUR with a low forecast of 3.071 EUR and a high forecast of 9.047 EUR.

What is the Revenue forecast for OPKO Health Inc?
Projected CAGR
3%

Over the last 1 year, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for OPKO Health Inc?
Projected CAGR
6%

Over the last 1 year, the compound annual growth rate for Gross Profit has been -6%. The projected CAGR for the next 5 years is 6%.

Back to Top
ALPHA SPREAD
Follow us
Join 351,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett